AOD 9604 works through direct activation of fat cell receptors, bypassing appetite signaling entirely
The Current State of AOD 9604 Research So, if its not an obesity drug, what are scientists studying now
Instead, it exists as a research compound, which means its quality, purity, and concentration can vary significantly between suppliers
Financially, you should know that peptides like 5-Amino-1MQ are not covered by insurance
Continued research and development in this field will likely make peptide medicine an increasingly vital component of modern healthcare
There is no human clinical trial establishing any effective or safe human dose, oral or injected